1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

David Einhorn Comments on Evonik

May 13, 2013 | About:

We initiated a long position in Evonik (Germany: EVK) [color=#444444; font-family: arial, sans-serif; font-size: small; line-height: 16px](GR:EVK), [/color]a global chemical business, through a private placement at an effective price of €29.13 per share, ahead of a public listing in April. EVK has a high quality portfolio of chemical assets in the U.S., Europe and Asia, including market leadership in methionine, a high margin, high structural growth business that tracks the demand for animal feed. EVK’s business is less cyclical than that of its European peers as demonstrated by its positive EBITDA growth each year even during the recession. EVK is currently in the middle of a capital investment cycle that we believe will enable it to grow its earnings power from €2.50 in 2012 to €4.00 per share in 2015/2016. We think that its combination of secular growth, superior asset quality, and low cyclicality makes EVK the premier European chemical company, which deserves a re-rating to a premium multiple.

From David Einhorn's 2013 first quarter investor letter.


Rating: 4.0/5 (2 votes)

Comments

Please leave your comment:


More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

User Generated Screeners


chentao1006non-fin
bkw82quality growing and cheap
TFC10% sharehold Yield
nycjacSmall companies
mvpfxshoot rog
James LiStrong Stocks 2017 version 2
James LiStrong Stocks 2017 version 1
pbarker46Shiller PE
pbarker46No losses for ten years
pbarker46BV growth
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK